(Updates with the latest stock movement in the first paragraph and headline.)

NeoGenomics (NEO) shares were up over 15% in Wednesday trading following its better-than-expected Q2 results.

Late Tuesday, the company reported Q2 adjusted earnings of $0.05 per diluted share, up from $0.03 a year earlier.

Analysts polled by FactSet expected $0.03.

Revenue for the quarter ended June 30 was $201.7 million, up from 181.3 million a year earlier.

Analysts expected $196.9 million.

The company said it now expects 2026 revenue of $802 million to $806 million, up from its prior range of $797 million to $803 million. Analysts expect $800.4 million.

Price: 15.51, Change: +2.11, Percent Change: +15.75